EMEA-000694-PIP04-18
Key facts
| Invented name |
Forxiga
|
| Active substance |
dapagliflozin
|
| Therapeutic area |
Uro-nephrology
|
| Decision number |
P/0373/2018
|
| PIP number |
EMEA-000694-PIP04-18
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of chronic kidney disease
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AstraZeneca AB (UK)
Tel. +44 2037496236 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|